- Home
- RZLT vs ANGO Comparison
RZLT vs ANGO Comparison
Compare RZLT & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- ANGO
- Stock Information
- Founded
- RZLT 2010
- ANGO 1988
- Country
- RZLT United States
- ANGO United States
- Employees
- RZLT N/A
- ANGO N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- ANGO Medical/Dental Instruments
- Sector
- RZLT Health Care
- ANGO Health Care
- Exchange
- RZLT Nasdaq
- ANGO Nasdaq
- Market Cap
- RZLT 361.3M
- ANGO 400.8M
- IPO Year
- RZLT N/A
- ANGO 2004
- Fundamental
- Price
- RZLT $7.20
- ANGO $10.01
- Analyst Decision
- RZLT Strong Buy
- ANGO Strong Buy
- Analyst Count
- RZLT 5
- ANGO 3
- Target Price
- RZLT $12.50
- ANGO $19.00
- AVG Volume (30 Days)
- RZLT 680.6K
- ANGO 379.1K
- Earning Date
- RZLT 09-18-2025
- ANGO 10-02-2025
- Dividend Yield
- RZLT N/A
- ANGO N/A
- EPS Growth
- RZLT N/A
- ANGO N/A
- EPS
- RZLT N/A
- ANGO N/A
- Revenue
- RZLT N/A
- ANGO $292,498,000.00
- Revenue This Year
- RZLT N/A
- ANGO $7.13
- Revenue Next Year
- RZLT N/A
- ANGO $6.28
- P/E Ratio
- RZLT N/A
- ANGO N/A
- Revenue Growth
- RZLT N/A
- ANGO N/A
- 52 Week Low
- RZLT $2.22
- ANGO $5.83
- 52 Week High
- RZLT $7.46
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- RZLT 78.84
- ANGO 68.60
- Support Level
- RZLT $6.23
- ANGO $8.65
- Resistance Level
- RZLT $6.64
- ANGO $9.20
- Average True Range (ATR)
- RZLT 0.30
- ANGO 0.32
- MACD
- RZLT 0.05
- ANGO 0.17
- Stochastic Oscillator
- RZLT 86.56
- ANGO 98.21
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.